It is not known if Ozempic will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use Ozempic if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in Ozempic Before using Ozempic , tell your health care provider if you have any other medical conditions, including if you: have or have had problems with your pancreas have a history of vision problems related to your diabetes have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) are pregnant or breastfeeding or plan to become pregnant or breastfeed

Phase 2 Clinical Trial Data The landmark Phase 2 trial of retatrutide in obesity was a 48-week, randomized, double-blind, placebo-controlled study published in The New England Journal of Medicine in 2023
It is backed by third-party testing and a safe inactive ingredient profile, while product-specific testing is not currently verified by SuppCo
Subsequent case reports have documented similar concerning events, including the Gulak and Murphy series describing a 70-year-old male who regurgitated large-volume particulate contents during laryngoscopy two days after semaglutide cessation [5]
Cardiovascular Research Research on cardiovascular biomarkers, lipid profiles, and blood pressure trajectories
Units assume a U100 insulin syringe (100 units = 1 mL on U-100)